Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Journal of Clinical Medicine
|
March 10, 2022
HIV-Associated Lymphomas: Progress and New Challenges
Georgios N Pongas, Juan C Ramos
Oncotarget
|
November 16, 2017
PI3Kδ inhibition causes feedback activation of PI3Kα in the ABC subtype of diffuse large B-cell lymphoma
Georgios N Pongas, Christina M Annunziata, Louis M Staudt
Clinical Case Reports
|
September 6, 2021
Mantle cell lymphoma involving the thyroid gland
Georgios N Pongas, Juan Pablo Alderuccio, Jennifer R Chapman, et al.
British Journal of Haematology
|
October 31, 2025
Peripheral blood involvement in extra-nodal marginal zone lymphoma
Izidore S Lossos, Juliette L Martin, Jennifer R Chapman, et al.
Antimicrobial Agents and Chemotherapy
|
July 29, 2009
Culture medium composition affects the lethality of Cunninghamella bertholletiae in a fly model of mucormycosis
Georgios N Pongas, Ronen Ben-Ami, Russell E Lewis, et al.
Antimicrobial Agents and Chemotherapy
|
October 20, 2010
Activity of deferasirox in Mucorales: influences of species and exogenous iron
Russell E Lewis, Georgios N Pongas, Nathaniel Albert, et al.
Blood Advances
|
February 18, 2026
Patterns of Care and Clinical Outcomes in Systemic Peripheral T-cell Lymphoma: The LEO-MER Prospective Cohort Study
Jia Ruan, Zhengming Chen, Melissa C Larson, et al.
Blood Advances
|
February 24, 2026
Benefit of rituximab maintenance after first-line bendamustine-rituximab in patients with mantle cell lymphoma
Yucai Wang, Melissa C Larson, Steven R Hwang, et al.
Blood Advances
|
December 11, 2025
Benefit of Rituximab Maintenance After First-line Bendamustine-Rituximab in Patients with Mantle Cell Lymphoma
Yucai Wang, Melissa C Larson, Steven R Hwang, et al.
Blood Cancer Journal
|
April 25, 2026
Mantle cell lymphoma outcomes following sequential first-line bendamustine-rituximab and second-line Bruton's tyrosine kinase inhibitor therapy
Yucai Wang, Melissa C Larson, Steven R Hwang, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Journal of Clinical Medicine
|
March 10, 2022
HIV-Associated Lymphomas: Progress and New Challenges
Georgios N Pongas, Juan C Ramos
Oncotarget
|
November 16, 2017
PI3Kδ inhibition causes feedback activation of PI3Kα in the ABC subtype of diffuse large B-cell lymphoma
Georgios N Pongas, Christina M Annunziata, Louis M Staudt
Clinical Case Reports
|
September 6, 2021
Mantle cell lymphoma involving the thyroid gland
Georgios N Pongas, Juan Pablo Alderuccio, Jennifer R Chapman, et al.
British Journal of Haematology
|
October 31, 2025
Peripheral blood involvement in extra-nodal marginal zone lymphoma
Izidore S Lossos, Juliette L Martin, Jennifer R Chapman, et al.
Antimicrobial Agents and Chemotherapy
|
July 29, 2009
Culture medium composition affects the lethality of Cunninghamella bertholletiae in a fly model of mucormycosis
Georgios N Pongas, Ronen Ben-Ami, Russell E Lewis, et al.
Antimicrobial Agents and Chemotherapy
|
October 20, 2010
Activity of deferasirox in Mucorales: influences of species and exogenous iron
Russell E Lewis, Georgios N Pongas, Nathaniel Albert, et al.
Blood Advances
|
February 18, 2026
Patterns of Care and Clinical Outcomes in Systemic Peripheral T-cell Lymphoma: The LEO-MER Prospective Cohort Study
Jia Ruan, Zhengming Chen, Melissa C Larson, et al.
Blood Advances
|
February 24, 2026
Benefit of rituximab maintenance after first-line bendamustine-rituximab in patients with mantle cell lymphoma
Yucai Wang, Melissa C Larson, Steven R Hwang, et al.
Blood Advances
|
December 11, 2025
Benefit of Rituximab Maintenance After First-line Bendamustine-Rituximab in Patients with Mantle Cell Lymphoma
Yucai Wang, Melissa C Larson, Steven R Hwang, et al.
Blood Cancer Journal
|
April 25, 2026
Mantle cell lymphoma outcomes following sequential first-line bendamustine-rituximab and second-line Bruton's tyrosine kinase inhibitor therapy
Yucai Wang, Melissa C Larson, Steven R Hwang, et al.
Page
of 1